Further research into the functions of TMEM181, RASA3, BCAR3, and MCTP2 in immune cells may elucidate the molecular pathways and regulatory networks underlying SLE pathophysiology, thereby providing a theoretical foundation for the development of new immunomodulatory therapies. The gene discussed is TMEM181; the disease is systemic lupus erythematosus.